Abiopharma

News list

(30% Negative) Clene Inc. (CLNNW) Announces Regulatory Update

Full text

News bot Jan. 30, 2026, 8:10 a.m.
📋 Clene Inc. (CLNNW) - Regulatory Update

Filing Date: 2026-01-13

Accepted: 2026-01-13 16:36:05

Event Type: Regulatory Update

Event Details:

Clene Inc. (CLNNW) Announces Regulatory Update Clene Inc. (CLNNW) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: • PDUFA Date: january 12, 2026 • Applications: NDA (New Drug Application) • Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency) • Status: Approved, Rejected, Delayed • Committee Actions: Positive Opinion Clinical Development:
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Clene Inc.
- Ticker Symbol: CLNNW